Analysts, along with Dr. Cole Claiborne discuss AVTX-009 in hidradenitis suppurativa (HS).on an Analyst/Industry conference call to be held on October 22 at 1 pm.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AVTX:
- Avalo Therapeutics management to meet with Piper Sandler
- Avalo Therapeutics Highlights AVTX-009 Potential in New Presentation
- Avalo Therapeutics Strengthens Leadership with Key Appointments
- Avalo Therapeutics appoints Boyd as CBO, Ivanowicz as SVP, Human Resources
- Avalo Therapeutics Appoints Kevin Lind to Board